Results 211 to 220 of about 160,488 (298)

Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies. [PDF]

open access: yesCancers (Basel)
Goradia R   +5 more
europepmc   +1 more source

Toward Tailored Metastability: Exploring Oxanorbornene Chemical Space for Structure–Stability Relationships With Atypical Furan Diels–Alder Adducts

open access: yesChemistryEurope, Volume 4, Issue 5, May 2026.
The furan Diels–Alder reaction is a versatile platform for metastable and biobased molecules and materials. By accessing atypical oxanorbornene adducts, we expand furan Diels–Alder chemistry beyond activated addends and show that cycloreversion stability can be tuned over six orders of magnitude, revealing structure–stability relationships that enable ...
Eva Harsevoort   +2 more
wiley   +1 more source

Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled Analysis. [PDF]

open access: yesJ Clin Med
Nicolazzini M   +16 more
europepmc   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

open access: yesInternational Journal of Cancer, Volume 158, Issue 9, Page 2440-2451, 1 May 2026.
What's new? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel   +21 more
wiley   +1 more source

Requiring Caution in the Interpretation of Donor‐Derived Cell‐Free DNA Levels During Cancer Treatment in a Kidney Transplant Recipient.: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Donor‐derived cfDNA (dd‐cfDNA) indicates allograft rejection when > 1% of total cfDNA, but tumor‐derived cfDNA can interfere in cancer patients. Case Presentation A 61‐year‐old male kidney transplant recipient with metastatic renal cell carcinoma (RCC) initiated avelumab and axitinib.
Nanaka Katsurayama   +9 more
wiley   +1 more source

Complicated renal angiomyolipoma with renal vein fat embolism mimicking lipid-rich renal cell carcinoma: A case report. [PDF]

open access: yesRadiol Case Rep
Alsaleh B   +6 more
europepmc   +1 more source

Evaluation of Acute Exposure to Combustible and Novel Tobacco Products Using an In Vitro Human Airway Organ Tissue Equivalent Model

open access: yesJournal of Applied Toxicology, Volume 46, Issue 5, Page 1548-1565, May 2026.
ABSTRACT Despite the well‐known risks of tobacco use, tobacco exposure remains a major contributor to morbidity and mortality worldwide. Although cigarette use has declined, the popularity of novel tobacco products (NTPs), such as electronic cigarettes (ECs) and heated tobacco products (HTPs), has increased.
Timothy S. Leach   +8 more
wiley   +1 more source

Gut Microbiota and Extraintestinal Cancers: Mechanistic Insights and Microbiome‐Targeted Interventions

open access: yesJGH Open, Volume 10, Issue 5, May 2026.
ABSTRACT The gut microbiota is a dynamic community of bacteria, viruses, fungi, and archaea that plays a pivotal role in regulating host immunity, metabolism, and systemic homeostasis. Dysbiosis, characterized by an imbalance in the microbial composition, is being increasingly recognized as a contributor not only to gastrointestinal cancers but also to
Rishi Chowdhary   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy